Skip to main content
Log in

Pharmacokinetic interactions between felodipine and metoprolol

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

This double-blind, cross-over study in healthy male subjects evaluated the pharmacokinetics of felodipine and metoprolol given both separately and in combination. During three, five-day study periods, felodipine 10 mg b.d., metoprolol 100 mg b.d. and a combination of the two, were given in random order. There was at least a 7-day washout period between each pharmacokinetic study day. Plasma levels of unchanged felodipine and metoprolol were measured for 24 h after the last dose, on the 5th day of each treatment period.

Eight subjects, aged 19–22 years, completed the study. Both felodipine and metoprolol, given alone and in combination, were well tolerated.

None of the felodipine pharmacokinetic variables (tmax, Cmax, Cmin, AUC (0–12) and t1/2) changed significantly when felodipine and metoprolol were given in combination. Cmax and AUC (0–12) for metoprolol increased significantly when metoprolol and felodipine were combined, although tmax, Cmin and t1/2 for metoprolol remained unchanged. The changes in metoprolol pharmacokinetics induced by felodipine are small and unlikely to be clinically important.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Edgar B, Hoffmann K-J, Lundborg P, Regardh C-G, Ronn D, Weidolf L (1985) Absorption, distribution and elimination of felodipine in man. Drugs 29 [Suppl 2]: 9–15

    Google Scholar 

  2. Hansson BG, Lyngstam G, Lyngstam O, Ryder L, Thilen U (1985) Antihypertensive effect of felodipine combined with beta-blockade. Drugs 29 [Suppl 2]: 131–135

    Google Scholar 

  3. Aberg H, Lindsjo M, Morlin B (1985) Comparative trial of felodipine and nifedipine in refractory hypertension. Drugs 29 [Suppl 2]: 117–123

    Google Scholar 

  4. McLean AJ, Skews H, Bobik A, Dudley FJ (1980) Interaction between oral propranolol and hydralazine. Clin Pharmacol Ther 27: 726–732

    Google Scholar 

  5. Jack DB, Kendall MJ, Dean S, Laugher S, Zaman R, Tenneson ME (1982) The effect of hydralazine on the pharmacokinetics of three different beta-adrenoceptor antagonists: Metoprolol, nadolol and acebutolol. Biopharm Drug Dispos 3: 46–54

    Google Scholar 

  6. Ahnoff M (1985) Determination of felodipine in plasma by capillary gas chromatography with electron capture detection. J Pharm Biomed Analysis 2: 519–526

    Google Scholar 

  7. Ervik M (1975) Quantitative determination of metoprolol in plasma and urine by gas chromatography. Acta Pharmacol Toxicol 36 [Suppl V]: 136–144

    Google Scholar 

  8. Kendall MJ, Jack DB, Laugher SJ, Lobo J, Smith SR (1984) Lack of a pharmacokinetic interaction between nifedipine and the beta-blockers metoprolol and atenolol. Br J Clin Pharmacol 18: 331–335

    Google Scholar 

  9. Wilkins MR, Woods KL, Jack DB, Kendall MJ, Laugher SJ (1985) Separate and combined effects of nadolol and nifedipine on the cardiac response to exercise. Eur J Clin Pharmacol 28: 113–117

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, S.R., Wilkins, M.R., Jack, D.B. et al. Pharmacokinetic interactions between felodipine and metoprolol. Eur J Clin Pharmacol 31, 575–578 (1987). https://doi.org/10.1007/BF00606633

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00606633

Key words

Navigation